ClinicalTrials.gg
Sign In

Neuroblastoma clinical trials

The registry lists 675 studies for Neuroblastoma across more than 10 countries. 127 are recruiting or about to start. 393 of them are mainly about Neuroblastoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Esthesioneuroblastoma, Olfactory: 750 studies, 131 open.

ClinicalTrials.gov finds 772 studies for Neuroblastoma. How that becomes 675 here

This page counts the studies the registry files under Neuroblastoma, and those it files under no condition that list Neuroblastomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 772Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −75Filed under a narrower condition, counted on its own pageEsthesioneuroblastoma, Olfactory 72 · Ganglioneuroblastoma 2
  3. −11List Neuroblastoma as a condition, but the registry did not file them under itMost often written as “Disseminated Neuroblastoma” (3), “Localized Resectable Neuroblastoma” (1), and “Neuroblastoma. CNS” (1). The registry filed them under other conditions only, most often Recurrence (5) and Pdgfra-Associated Chronic Eosinophilic Leukemia (3).
  4. −11Match it another way7 name it in the title and 4 in a keyword.
  5. 675The count on this page22 of them list Neuroblastoma in their own words; the registry filed them under no condition.

Get an email when these change. Save the Neuroblastoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
339
Recruiting
104
Terminated
66
Active, not recruiting
57
Status unknown
52
Withdrawn
26

Phase

Phase 1
267
Phase 2
255
Phase 3
47
Early Phase 1
16
Phase 4
4

Where

United States
468
Canada
88
France
54
United Kingdom
52
Australia
50
China
42

Who runs them

National Cancer Institute (NCI) (69) · Children's Oncology Group (59) · Memorial Sloan Kettering Cancer Center (51) · St. Jude Children's Research Hospital (24) · New Approaches to Neuroblastoma Therapy Consortium (24) · Giselle Sholler (19) · Baylor College of Medicine (14) · Fred Hutchinson Cancer Center (14)

What is being tested here

Drugs under test in Neuroblastoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dinutuximab7422
Naxitamab7014
Cyclophosphamide5639
Temozolomide5122
Irinotecan5121
Melphalan4321
Carboplatin3726
Vincristine3215
Etoposide2627
Topotecan2119

Drug classes tested here Alkylating agents 10 open · Tyrosine kinase inhibitors (TKIs) 4 open · Antimitotic agents 3 open · Antimetabolites 2 open · HDAC inhibitors 2 open

Coming up

11phase 3 studies under way
55studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 104 Neuroblastoma studies recruiting now, 25 (24%) set no upper age limit and 74 (71%) stop at 75 or younger. 101 (97%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (3%) take healthy volunteers.

Recruiting studies that take each age, of 104
AgeWomenMen
10100 (96%)100 (96%)
1899 (95%)99 (95%)
3053 (51%)53 (51%)
4035 (34%)35 (34%)
5033 (32%)33 (32%)
6531 (30%)31 (30%)
7530 (29%)30 (29%)
8529 (28%)29 (28%)

Across all 675 studies, recruiting or not: 70% stop at 75 or younger and 68% at 65; 94% take children; 0% are for women only and <1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neuroblastoma studies take

Of 86 phase 1 interventional studies under Neuroblastoma, half reached primary completion within 83 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 183 mo60–114 · 86 studies—89 mo65–117 · 73 studies
Phase 1/280 mo62–115 · 35 studies——
Phase 274 mo52–99 · 67 studies—74 mo52–99 · 62 studies
Phase 396 mo80–122 · 19 studies——
Observational213 mo74–304 · 34 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Results posted1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 675. Browse all 675 → or search them.